Alprenoxime
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| ChEMBL | |
| Chemical and physical data | |
| Formula | C15H22N2O2 |
| Molar mass | 262.353 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| NY (what is this?) (verify) | |
Alprenoxime is a beta blocker.[1] It is a prodrug to alprenolol.[1]
References
- ^ a b Prokai L, Wu WM, Somogyi G, Bodor N (May 1995). "Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue". Journal of Medicinal Chemistry. 38 (11): 2018–20. doi:10.1021/jm00011a021. PMID 7783133.
| Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
|---|---|---|---|---|---|
| Other antagonists |
| ||||
| |||||
Adrenergic receptor modulators | |||||
|---|---|---|---|---|---|
| α1 |
| ||||
| α2 |
| ||||
| β |
| ||||
| |||||
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.